Your search matched 7 results
SCOTUS is weighing its options on a number of healthcare cases; using social activism to tip the scales for your brand reputation; and crowdfunding for what?
Climate change is named a top 10 health threat and we’ve broken down the conundrum for pharma companies regarding activating on the issue.
The Week That Was: ... | Blog
Our favorite #healthpolicyvalentines, new FDA guidance regarding complex generics and what you need to know now regarding data security from pharma and patient perspectives.
Policymakers continue their focus on drug pricing and may also have eyes for changes to the Orphan Drug Act.
You think you’re busy?
Winter is coming… in May.